CTSA Evaluation Steering Committee: Update

1
CTSA Evaluation Steering Committee Update

• NIH Subcommittee Co-Chairs
• Lori Mulligan, NCRR
• Margaret Ames, NCI

2
National CTSA Consortium EvaluationPurpose

• Evaluate short and long term effectiveness of the
  CTSA program
• Assess how the CTSAs function as a collective,
  national consortium
• Determine success/impact in transforming clinical
  and translational research
• Disseminate findings to Consortium, researchers,
  stakeholders, Congress, etc.

3
Congressional Interest

• Reauthorization
• NIH Reform Act of 2006
• Funding/infrastructure for pediatric clinical
  research
• House Senate Committee Report Requests
• Support of Clinical Investigators (Due 3/1/2007)
• Support for pilot studies
• Clinical and Translational Research (Due
  4/1/2007)
• Describe implementation of CTSA model and
  identify barriers
• GCRCs/CTSAs (Due 7/1/2007)
• Status of implementing and evaluating CTSA program

4
National CTSA Consortium Evaluation Multiple
Inputs into Planning Process
CTSA Evaluation Steering Committee
External Advisors
National CTSA Consortium Evaluation
Other CTSA Steering Committees (i.e.,
Informatics, Translation, Education, etc.)
Professional Evaluators (The Madrillon Group)
5
Progress to Date

• Convened CTSA Evaluation Steering Committee twice
• Awarded CTSA Evaluation Contract to
  MasiMax/Madrillon Group
• Created a Conceptual Framework of the Evaluation
• Solicited Self-evaluation summary through CTSA
  APR
• Selected an Interim Chair - Harold Pincus from
  Columbia
• Currently working on
• National Goals and Questions
• Analysis of Local Self Evaluation Plans to
  identify common indicators
• Wiki page for CTSA institutions to share documents

6
Developing National CTSA Evaluation Goals,
Questions, and Indicators
The Madrillon Group joins CTSA Evaluation Team
January
First National CTSA Evaluation Steering Committee
Meeting
February
Analysis of CTSA Proposed Evaluation Plans
NIH develops draft overarching Evaluation Goals
questions, with input from The Madrillon Group.
March
Review and edit of Proposed CTSA Evaluation Plans
by respective grantees
mouse
April
Discuss Draft National Goals/Questions and Status
of Consortium Indicator Analysis with CTSA Eval SC
Update PI Steering Committee on National CTSA
Evaluation Progress
May
NIH to circulate draft National goals, questions
and indicators to Eval reps and other SC POCs for
feedback
MRI insertiontube
NIH discusses National goals, questions, and
indicators with NARRC CTSA Working Group
June
Finalize National Goals, Questions, and Indicators
July
NCRR
7
National Evaluation Goals of the CTSA Program

• Scientist
• Institution
• Consortium

• Assess the recruitment, retention, and career
  advancement of clinical and translational science
  researchers
• Assess the effectiveness of the CTSA to integrate
  clinical and translational science at the
  Institution
• Assess the effectiveness of an integrated
  national CTSA Consortium

8
National Evaluation Goals of the CTSA Program

• Consortium (continued)
• Science

• Assess the effectiveness of the National
  Institutes of Health as a partner with the CTSA
  Consortium
• Assess the acceleration of the translation of
  basic research into clinical studies
• Assess the acceleration of clinical studies into
  community practice

9
National Evaluation Goals of the CTSA Program

• Health Practice
• Communities Society

• Assess the dissemination of new methods, tools,
  and resources into medical practice
• Assess the impact of the CTSA Consortium on
  improving public knowledge and involvement in
  clinical and translational research
• Assess the impact the CTSA program has on
  reducing morbidity and mortality

10
(No Transcript)
11
NIH CTSA Evaluation Efforts to Ensure
Accountability
Congress, Researchers, Patients, Stakeholders,
Public
CTSA NATIONAL EVALUATION (NCRR, NIH, The
Madrillon Group)
CTSA 1 INSTITUTIONAL SELF- EVALUATION
CTSA 2 INSTITUTIONAL SELF-EVALUATION
CTSA 3 INSTITUTIONAL SELF-EVALUATION